In order to assess the biological function of proteins and their modifications for understanding signaling mechanisms within cells as well as specific biomarkers to disease, it is important to study the change of proteome under different experimental conditions. The emerging technology of mass spectrometry-based quantitative proteomics provides a powerful tool to quantitatively and systematically assess quantitative differences in protein profiles of distinct samples and is increasingly becoming a significant component of biomedical and clinical research.